1. Minimum Inhibitory Concentration (MIC) of the Novltex Analogues (1–10) against MRSA along with Their Configuration.
| analogues configuration |
|||||||||
|---|---|---|---|---|---|---|---|---|---|
| synthesized Novltex analogues | Phe1 | Leu2 | Lys3 | Ser4 | Thr5 | Ala6 | Leu7 | Leu8/Ile8 | MIC against MRSA ATCC 33591 (μg/mL) |
| 1 | L | D | D | L | L | L | D | L | 8 |
| 2 | L | D | D | L | D | L | D | L | 32 |
| 3 | D | L | L | D | D | L | L | L | 32 |
| 4 | L | D | D | L | D | L | L | L | 2–4 |
| 5 | D | L | D | L | D | L | L | L | >32 |
| 6 | L | D | L | D | D | L | L | L | >32 |
| 7 | D | D | L | L | D | L | L | L | 32 |
| 8 | L | L | L | L | D | L | L | L | >32 |
| 9 | D | D | D | D | D | L | L | L | 16 |
| 10 | L | D | D | L | D | L | L | L | 8 |
| vancomycin | 0.5–1 | ||||||||
Indicates the presence of l-Ile8 for analogue 10.
